| Theresa M. Snelling, M.a., Ccc-slp | |
|
9255 W Alameda Ave, Unit C, Lakewood, CO 80226 | |
| (303) 232-5711 | |
| (303) 232-5711 |
| Full Name | Theresa M. Snelling, M.a., Ccc-slp |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 9255 W Alameda Ave, Lakewood, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013253517 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Theresa M. Snelling, M.a., Ccc-slp 9255 W Alameda Ave., Unit C, Lakewood, CO 80226 Ph: (303) 232-5711 | Theresa M. Snelling, M.a., Ccc-slp 9255 W Alameda Ave, Unit C, Lakewood, CO 80226 Ph: (303) 232-5711 |
News Archive
Lt. Governor Casey Cagle today joined Georgia Bio, the Georgia Research Alliance, the Metro Atlanta Chamber and the Innovation Crescent business community in announcing the launch of the Georgia Bioscience Commercialization Center (GBCC), which will act as a start-up catalyst and resource center for bioscience entrepreneurs in Georgia.
Amplimmune, Inc. today announced that it has entered into a broad strategic alliance with GlaxoSmithKline (GSK) to further develop PD-1 targeting therapies that may be effective in the treatment of cancer and other diseases. GSK will obtain exclusive worldwide rights to AMP-224 as well as other potential next generation fusion proteins that target PD-1.
At the opening of the U.N. Commission on Life-Saving Commodities for Women and Children on Tuesday, U.N. Secretary-General Ban Ki-moon praised the commission but "said that much remains to be done to save the lives of the 800 women and more than 20,000 children who die every day from preventable causes," the U.N. News Centre reports.
UT Southwestern Medical Center scientists report the first successful blocking of tumor development in a genetic mouse model of an incurable human cancer.
Scientists at Schepens Eye Research Institute have discovered what chemical in the eye triggers the dormant capacity of certain non-neuronal cells to transform into progenitor cells, a stem-like cell that can generate new retinal cells.
› Verified 7 days ago
Brenna M Schillinger, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1401 S Kendall St, Lakewood, CO 80232 Phone: 303-982-9720 | |
Patricia Rogers, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13175 W Green Mountain Dr, Lakewood, CO 80228 Phone: 303-982-9500 | |
Jannette Josephine Martin, MA, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7475 W 5th Ave, Suite 215, Lakewood, CO 80226 Phone: 303-987-1285 | |
Nishma Strode, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2001 Hoyt St, Lakewood, CO 80215 Phone: 303-759-1192 | |
Jami Weinstein, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2800 Youngfield St, Lakewood, CO 80215 Phone: 720-513-0582 | |
Shana Turner Cook, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1940 Willow Ln, Lakewood, CO 80215 Phone: 720-217-5323 |